Skip to main content
BioSyent Inc. logo

BioSyent Inc. — Investor Relations & Filings

Ticker · RX ISIN · CA0906901081 TSXV Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2021-05-27 Regulatory Filings
Country CA Canada
Listing TSXV RX

About BioSyent Inc.

https://www.biosyent.com/

BioSyent Inc. is a profitable, growth-oriented specialty pharmaceutical company focused on enhancing patient lives by addressing unmet medical needs. The company's primary business model involves sourcing, in-licensing, and acquiring innovative pharmaceutical and healthcare products globally for development and commercialization. BioSyent markets a diverse portfolio of products, including prescription, over-the-counter, and behind-the-counter options, primarily serving markets in Canada and select international regions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-05-27 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short press release announcing the scheduled date for the company's Q1 2021 earnings release. It does not contain any actual financial results or detailed financial data, only the announcement of when the earnings will be reported and a mention of a presentation to be made available. The document length is only 1497 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about upcoming earnings releases are classified as Earnings Release (ER) announcements if they contain key highlights, but this document does not contain any financial highlights or results, only the schedule. Therefore, it is best classified as a Regulatory Filing (RNS) as a general announcement about the earnings release date and presentation availability, not the earnings release itself.
2021-05-20 English
Annual report - English.pdf
Annual Report Classification · 100% confidence The document is titled 'BioSyent Inc. 2020 Annual Report' and contains detailed sections typical of an annual report, including financial highlights, business units, letter from the chairman, board of directors, management discussion and analysis, audited consolidated financial statements, and independent auditor's report. The content covers the full fiscal year ended December 31, 2020, with comprehensive financial data and analysis. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-05-06 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for an Annual General and Special Meeting scheduled for May 26, 2021. It includes instructions for appointing proxyholders, voting methods, and voting recommendations for election of directors, appointment of auditors, and approval of an incentive stock option plan. The content is focused on soliciting votes and providing proxy voting instructions rather than presenting financial data or detailed reports. There is no substantive financial information or management discussion included. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the meeting.
2021-05-05 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Voting Instruction Form (VIF) for an Annual General and Special Meeting scheduled for May 26, 2021. It includes instructions for shareholders on how to vote, appoint proxies, and details on voting methods (telephone, internet, mail). It references the election of directors, appointment of auditors, and approval of an incentive stock option plan. The document is a proxy solicitation material designed to collect shareholder votes rather than the actual meeting minutes, voting results, or the annual report itself. It is not a full Annual Report (10-K), nor a Declaration of Voting Results (DVA), but rather a solicitation for votes ahead of the AGM. Therefore, the document best fits the category of Proxy Solicitation & Information Statement (PSI). The document length (8218 characters) and content confirm it is not a brief announcement or a report publication notice, but a detailed proxy voting form.
2021-05-05 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual General and Special Meeting of Shareholders for BioSyent Inc. It outlines the agenda for the meeting, including receiving audited financial statements, electing directors, appointing auditors, and other shareholder matters. It also provides logistical details about the meeting date, location, proxy voting, and webcast information. The document does not contain the actual financial statements or detailed reports but serves as an announcement and invitation to the shareholders for the meeting. The length is relatively short (3124 characters), and it is clearly a notice rather than a full report or presentation. Therefore, it fits the category of AGM Information (AGM-R).
2021-05-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.